Malcolm B. Segal

The Choroid Plexuses and the Barriers Between the Blood and the Cerebrospinal Fluid

Abstract1. The fluid homeostasis of the brain depends both on the endothelial blood–brain barrier and on the epithelial blood–cerebrospinal fluid (CSF) barrier located at the choroid plexuses and the outer arachnoid membrane.2. The brain has two fluid environments: the brain interstitial fluid, which surrounds the neurons and glia, and the CSF, which fills the ventricles and external surfaces of the central nervous system.3. CSF acts as a fluid cushion for the brain and as a drainage route for the waste products of cerebral metabolism.4. Recent findings suggest that CSF may also act as a “third circulation” conveying substances secreted into the CSF rapidly to many brain regions.

PERMEABILITY OF THE DEVELOPING BLOOD-BRAIN BARRIER TO 14C-MANNITOL USING THE RAT IN SITU BRAIN PERFUSION TECHNIQUE

The brain penetration of 14C-mannitol was investigated using a bilateral in situ brain perfusion technique followed by capillary depletion analysis. This technique measures the uptake of slowly penetrating solutes in the absence of the systemic circulation, and separates accumulation in brain endothelial cells from uptake into brain parenchyma. Penetration of 14C-mannitol was linear up to 30 min in rats aged 1, 2, 3 weeks and in adults. The brain mannitol space was higher in 1-week-old neonatal rats compared with adults (P < 0.05) and was due to a greater initial volume of distribution (Vi) for mannitol in the neonates, and not due to an elevated transfer rate (K(in)). Thirty percent of mannitol in the neonatal brain was associated with the capillary containing fraction, whereas in the adult only 13% was found in this fraction. This suggests that the permeability of the blood-brain barrier to mannitol does not change significantly with development but that more mannitol is associated with endothelial cells in the neonate. An investigation of 14C-glycine uptake was also carried out, and unlike mannitol the K(in) was greater in the neonate compared to the adult suggesting an elevated rate of transfer for this amino acid into the neonatal rat brain.

New Concepts of a Blood—Brain Barrier

Developing Views of the Blood-Brain Barrier M.W.B. Bradbury. Development of the Blood-Brain Barrier B. Engelhart, W. Risau. Electrical Resistance Measurements of Blood-Brain Barrier Permeability A.M. Butt. The Application of Quantitative Immunocytochemistry for the Evaluation of Blood-Brain Barrier to Exogenous Albumin A.W. Vorbrodt. Endothelin as a Mediator of Blood-Brain Barrier Function M. Spatz, et al. The Role of the Endothelial Cell Surface Charge for Blood-Brain Barrier Function B.B. Johanssen. Capillary Permeability in Central and Peripheral Nerve Tissue in Streptozotocin Diabetes in the Anaethetised Rat G.G. Pinter, M.W.B. Bradbury. Serotonin as a Mediator of Increased Microvascular Permeability of the Brain and Spinal Cord: Experimental Observations in Anaesthetised Rats and Mice H.S. Sharma, et al. Molecular Regulation of Blood-Brain Barrier Glut1 Glucose Transporter W.M. Pardridge. The Dependency of Influx across the Blood-Brain Barrier on Blood Flow and the Apparent Flowindependence of Glucose Influx during Stress J.D. Fenstermacher, et al. Brain-Blood Barrier Removal of DOPA: Role in Regulation of Dopamine Synthesis and Treatment of Parkinsons Disease A. Gjedde, et al. 20 additional articles. Index.

An introduction to the blood-brain barrier

History of basic concepts transport of glucose and amino-acids in the central nervous system peptides and proteins transport of some precursors of nucleotides and some vitamins experimental models in the study of pathology of the blood-brain barrier.

A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig

The existence of an immunological blood-brain barrier to homologous blood-borne immunoglobulin G (IgG) was investigated in the guinea pig using a vascular brain perfusion technique in situ. Cerebrovascular unidirectional transfer constants (Kin) for 125I-labeled IgG (2.5 micrograms/ml) estimated from the multiple-time brain uptake data, ranged from 0.53 to 0.58 ml min-1 g-1 X 10(3) in the parietal cortex, hippocampus, and caudate nucleus, the transfer rate being some 10 times higher than that for [3H]dextran (MW 70,000). In the presence of 4 mg/ml unlabeled IgG, unidirectional blood to brain transfer of 125I-IgG was markedly inhibited. Immunohistochemical analysis of the brain tissue after vascular perfusion with unlabeled IgG revealed a distribution of the blood-borne immunoglobulin in the endothelial cells of microvessels and in the surrounding perivascular tissue. It is concluded that there is a specific transfer mechanism for IgG at the blood-brain barrier in the guinea pig, which is saturated at physiological plasma levels of IgG.

Leptin transport at the blood--cerebrospinal fluid barrier using the perfused sheep choroid plexus model.

Leptin is secreted by adipose tissue and thought to regulate appetite at the central level. Several studies have explored the central nervous system (CNS) entry of this peptide across the blood-brain and blood-cerebrospinal fluid (CSF) barriers in parallel, but this is the first to explore the transport kinetics of leptin across the choroid plexus (blood-CSF barrier) in isolation from the blood-brain barrier (BBB). This is important as the presence of both barriers can lead to ambiguous results from transport studies. The model used was the isolated Ringer perfused sheep choroid plexus. The steady-state extraction of [(125)I]leptin (7.5 pmol l(-1)) at the blood face of the choroid plexus was 21.1+/-5.7%, which was greater than extraction of the extracellular marker, giving a net cellular uptake for [(125)I]leptin (14.0+/-3.7%). In addition, trichloroacetic acid precipitable [(125)I] was detected in newly formed CSF, indicating intact protein transfer across the blood-CSF barrier. Human plasma concentrations of leptin are reported to be 0.5 nM. Experiments using 0.5 nM leptin in the Ringer produced a concentration of leptin in the CSF of 12 pM (similar to that measured in humans). [(125)I]Leptin uptake at the blood-plexus interface using the single-circulation paired tracer dilution technique (uptake in <60 s) indicated the presence of a saturable transport system, which followed Michaelis-Menten-type kinetics (K(m)=16.3+/-1.8 nM, V(max)=41.2+/-1.4 pmol min(-1) g(-1)), and a non-saturable component (K(d)=0.065+/-0.002 ml min(-1) g(-1)). In addition, secretion of new CSF by the choroid plexuses was significantly decreased with leptin present. This study indicates that leptin transport at the blood-CSF barrier is via saturable and non-saturable mechanisms and that the choroid plexus is involved in the regulation of leptin availability to the brain.

Changes in the kinetics of the acidic amino acid brain and CSF uptake during development in the rat

Using a bilateral in situ brain perfusion technique, the rate of influx of the acidic amino acids, aspartate and glutamate, into both brain and CSF, were measured in the rat. The kinetic constants for uptake of these amino acids across the blood-brain and blood-CSF barriers in neonatal (1-week-old) and adult (7-10 weeks-old) rats were calculated; the half saturation constant (K(m)) at both barriers did not change with age, whereas the maximal transport (Vmax) at both barriers was greater in the younger age group, and reduced by more than 50% with maturity. The diffusion constant Kd at the blood-brain barrier was not different from zero at either age, although at the blood-CSF barrier there was some diffusion at both ages, which did not change with maturity. The entry of these amino acids into the neonatal brain shown in our previous study can be explained by a greater maximal transport in the neonates which, coupled with the elevated plasma amino acid concentrations of the young animal, would result in higher blood-to-brain and blood-to-CSF flux in the neonate.

The entry of acidic amino acids into brain and CSF during development, using in situ perfusion in the rat

Previous studies using the rapid single pass blood to tissue uptake of substances by the capillaries of the blood-brain barrier, have failed to show significant uptake of acidic amino acids. However, by the use of a bilateral in situ brain perfusion in neonatal and adult rats, extending the perfusion time to 30 min, the carrier-mediated uptake of aspartate and glutamate into brain and CSF has been demonstrated. The ratios of 14C-acidic amino acids in the brain and CSF to that in perfusate were measured and represented as Rbrain and RCSF respectively, after 30 min, neonatal (1-week-old) Rbrain values for both amino acids were approximately twice that of adults, while neonatal RCSF for aspartate and glutamate were 3 to 5 times that of the adult. In contrast, there was no significant entry of NMDA into either compartment for both adults and neonates. The transfer coefficient, Kin into brain and CSF was also measured in relation to stages of development. In general the Kin values for brain and CSF for aspartate and glutamate were higher in the younger age groups than the adult group (1 week > 2 week > 3 week > or = adult). In 1- and 2-week-old rats entry into CSF appears to be higher than that of brain, whereas for adults entry into the brain tissue was dominant.

Neutral amino acid uptake by the isolated perfused sheep choroid plexus.

1. The uptake of neutral amino acids from the blood into the cells of the choroid plexus was studied by means of the rapid (less than 40 s) single‐circulation paired‐tracer dilution technique in the isolated perfused choroid plexus of the sheep. 2. The study provides the first direct evidence for the carrier‐mediated entry of neutral amino acids from blood into the cells of the choroid plexus. 3. In the terms of Christensens classification the presence of L‐amino acid carrier systems for large neutral amino acids with bulky side chains has been demonstrated. 4. No measurable uptake of [14C]methyl amino isobutyric acid ([14C]MeAIB) during a single passage through the choroid plexus circulation was demonstrated which indicates the probable absence of a significant ‘A’ transport system. 5. The uptake of small neutral amino acids such as glycine and L‐alanine was shown to be carrier‐mediated. Results suggest that these amino acids are mainly transported by the glycine and ASC carrier systems, respectively. 6. The results suggest that there is a similarity between the transport systems for neutral amino acids on the blood side of both the blood‐brain barrier and blood‐cerebrospinal fluid barrier, the exception being for the presence of a glycine carrier on the blood side of the choroid plexus.

Unidirectional uptake of enkephalins at the blood-tissue interface of the blood-cerebrospinal fluid barrier: a saturable mechanism

The cellular uptake at the blood-tissue interface of the blood-cerebrospinal fluid (CSF) barrier to tyrosyl-3,5-[3H]enkephalin-[5-L-leucine] (abbreviated to Leu-enkephalin) and of its synthetic analogue D-alanine2-tyrosyl-3,5-[3H]enkephalin-[5-D-leucine] (abbreviated to D-Ala2-D-Leu5-enkephalin) was studied in the isolated perfused choroid plexuses from the lateral ventricles of the sheep, using the rapid (less than 30 s), single circulation, paired-tracer dilution technique, in which D-[14C]-mannitol serves as an extracellular marker. Cellular uptake of peptides was estimated by directly comparing venous dilution profiles of [3H] and [14C] radioactivities in the absence and presence of unlabelled peptide, the N-terminal amino acid (L-tyrosine), the typical L-transport system substrate, 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid (BCH) and the inhibitor of aminopeptidase activity, bacitracin. The cellular uptake of both enkephalins was strongly (65-76%) but not completely inhibited by the addition of 5 mM unlabelled peptide to the bolus; the self-inhibition was significantly higher for D-Ala2-D-Leu5-enkephalin than for Leu-enkephalin. The addition to the bolus of L-tyrosine (5 mM), BCH (10 mM) or bacitracin (2 mM) reduced the 3H-radioactivity uptake by the choroid plexus of both enkephalins by 20-40%, the degree of inhibition being greater for [3H]-Leu-enkephalin than for its analogue. It is concluded that during single passage of enkephalins through the choroid plexus circulation, unidirectional uptake at the blood-tissue interface of the blood-CSF barrier consists of two components; a saturable component, which represents uptake of the intact peptide by the choroid epithelium, and a non-saturable component, which reflects enzymatic degradation of peptide in the blood and/or at the barrier, with a liberation of the N-terminal tyrosyl residue. Higher penetration of the blood-CSF barrier by D-Ala2-D-Leu5-enkephalin can be attributed to its greater resistance to hydrolysis.